Ordinary Adjustment | Solactive Transatlantic Healthcare Equity Index | Effective Date 8th October 2024
Solactive Transatlantic Healthcare Equity Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th October 2024:
CATALENT INC |
AXONICS INC |
FRESENIUS SE & CO KGAA |
MERCK KGAA |
UCB SA |
SANOFI SA |
NOVARTIS AG |
ROCHE HOLDING AG |
SONOVA HOLDING AG |
ESSILORLUXOTTICA |
LONZA GROUP AG |
ABBVIE INC |
ABBOTT LABORATORIES |
ADDUS HOMECARE CORP |
AMEDISYS INC |
RECORDATI SPA |
COLOPLAST AS CLASS B |
CONVATEC GROUP PLC |
SIEMENS HEALTHINEERS AG |
BECTON DICKINSON AND CO |
BIOMERIEUX |
ALCON INC |
GSK PLC |
BOSTON SCIENTIFIC CORP |
THE CIGNA GROUP |
QUEST DIAGNOSTICS INC |
DANAHER CORP |
DAVITA INC |
ENCOMPASS HEALTH CORP |
ELEVANCE HEALTH INC |
ENSIGN GROUP INC |
GILEAD SCIENCES INC |
HOLOGIC INC |
INTUITIVE SURGICAL INC |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERIT MEDICAL SYSTEMS INC |
MERCK & CO. INC. |
PRESTIGE CONSUMER HEALTHCARE INC |
PFIZER INC |
QIAGEN NV |
REGENERON PHARMACEUTICALS |
ROYALTY PHARMA PLC- CL A |
STERIS PLC |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
ZIMMER BIOMET HOLDINGS INC |